Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.
Por:
Armirola-Ricaurte C, Zonnekein N, Koutsis G, Amor-Barris S, Pelayo-Negro AL, Atkinson D, Efthymiou S, Turchetti V, Dinopoulos A, Garcia A, Karakaya M, Moris G, Polat AI, Yis U, Espinos C, Van de Vondel L, De Vriendt E, Karadima G, Wirth B, Hanna M, Houlden H, Berciano J and Jordanova A
Publicada:
1 jun 2024
Ahead of Print:
6 mar 2024
Resumen:
We describe 3 families with Charcot-Marie-Tooth neuropathy (CMT), harboring a homozygous NDUFS6 NM_004553.6:c.309+5G>A variant previously linked to fatal Leigh syndrome. We aimed to characterize clinically and molecularly the newly identified patients and understand the mechanism underlying their milder phenotype.
Filiaciones:
Armirola-Ricaurte C:
Molecular Neurogenomics group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Molecular Neurogenomics group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Zonnekein N:
Molecular Neurogenomics group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Molecular Neurogenomics group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Koutsis G:
Neurogenetics Unit, 1st Department of Neurology, Eginitio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Amor-Barris S:
Molecular Neurogenomics group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Molecular Neurogenomics group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Pelayo-Negro AL:
University Hospital Marqués de Valdecilla (IFIMAV), University of Cantabria, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain
Atkinson D:
Molecular Neurogenomics group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Molecular Neurogenomics group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Efthymiou S:
Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom
Turchetti V:
Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom
Dinopoulos A:
3rd Department of Pediatrics, Attiko Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Garcia A:
Service of Clinical Neurophysiology, University Hospital Marqués de Valdecilla, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain
Karakaya M:
Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases, University Hospital of Cologne, University of Cologne, Cologne, Germany
Moris G:
Service of Neurology, University Hospital Central de Asturias, University of Oviedo, Oviedo, Spain
Polat AI:
Department of Pediatric Neurology, Dokuz Eylül University, Izmir, Turkey
Yis U:
Department of Pediatric Neurology, Dokuz Eylül University, Izmir, Turkey
:
Rare Neurodegenerative Disease Laboratory, Centro de Investigación Príncipe Felipe (CIPF), CIBER on Rare Diseases (CIBERER), Valencia, Spain
Van de Vondel L:
Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
De Vriendt E:
Molecular Neurogenomics group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Molecular Neurogenomics group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Karadima G:
Neurogenetics Unit, 1st Department of Neurology, Eginitio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Wirth B:
Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases, University Hospital of Cologne, University of Cologne, Cologne, Germany
Hanna M:
Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom
Houlden H:
Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom
Berciano J:
University Hospital Marqués de Valdecilla (IFIMAV), University of Cantabria, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain
Jordanova A:
Molecular Neurogenomics group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
Molecular Neurogenomics group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
Department of Medical Chemistry and Biochemistry, Medical University-Sofia, Sofia, Bulgaria
Green Published
|